SLT (CognivAiD™) Improves Memory and Cognition in Individuals With Mild Cognitive Impairment: Clinical Trial Results

Investigator-initiated clinical trial of SLT (CognivAiD™) for mild cognitive impairment, led by Western Sydney University’s NICM Health Research Institute. Trial results reported that CognivAiD™ significantly improved key cognitive domains of episodic memory and executive function, and was well-tolerated. SINGAPORE, Nov. 09, 2023 (Korea Bizwire) – Moleac, a biopharmaceutical company pioneering innovative therapeutics in neurology, announced promising [...]